Breaking News, Collaborations & Alliances

Wyeth, GVK BIO Enter Research Alliance

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

GVK BIO has entered into a research agreement with Wyeth Pharmaceuticals, a division of Wyeth, to discover drug candidates focused on pre-defined discovery targets. GVK BIO will utilize in-house capabilities in discovery chemistry, informatics, biology and ADME to advance this program. GVK BIO will be responsible for identifying drug candidates, which will be transferred to Wyeth to advance these compounds towards clinical studies. Under the agreement, GVK BIO will receive an initial payment ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters